Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Status:
Terminated
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well palifosfamide works in treating patients with recurrent
germ cell tumors. Drugs used in chemotherapy, such as palifosfamide, work in different ways
to stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing